COMMUNIQUÉS West-GlobeNewswire
-
Biotricity Provides Fiscal 2018 First Quarter Updates for Shareholders
09/07/2018 - 14:00 -
Eyenovia Appoints Michael Rowe as Vice President of Marketing Ahead of Initiation of Multiple Phase III Programs
09/07/2018 - 13:30 -
Nephros Announces Preliminary Financial Results for Second Quarter 2018
09/07/2018 - 13:30 -
Spero Announces Positive Interim Phase 1 SAD/MAD Results for SPR994
09/07/2018 - 13:30 -
Assembly Biosciences Initiates Two Phase 2a Trials of ABI-H0731 for the Treatment of Hepatitis B Virus Infection
09/07/2018 - 13:05 -
Quark Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
09/07/2018 - 13:00 -
Tauriga Sciences, Inc. Successfully Petitions OTC MARKETS GROUP to Expedite the Up-Lisitng of its Shares to the OTCQB Exchange
09/07/2018 - 13:00 -
KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD
09/07/2018 - 13:00 -
Amryt Pharma plc: NHS England approves funding for Lojuxta
09/07/2018 - 13:00 -
FDA grants Fast Track Designation to Aclaris Therapeutics’ Investigational JAK Inhibitor for the treatment of Alopecia Areata
09/07/2018 - 13:00 -
Pluristem Signs Collaboration Agreement With Thermo Fisher Scientific
09/07/2018 - 13:00 -
Sunesis Pharmaceuticals Strengthens Senior Management Team
09/07/2018 - 13:00 -
Aptose Biosciences to Participate at the Oppenheimer & Co. Inc. Boston Oncology Insight Summit and 1x1 Day
09/07/2018 - 13:00 -
G1 Therapeutics Expands Executive Leadership Team with Appointment of John Demaree as Chief Commercial Officer and Stillman Hanson as General Counsel
09/07/2018 - 13:00 -
Translate Bio Announces Closing of Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for Infectious Diseases
09/07/2018 - 13:00 -
Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Parkinson’s Disease Dementia
09/07/2018 - 13:00 -
Zynerba Pharmaceuticals Initiates CONNECT-FX, a Pivotal Clinical Trial of ZYN002 in Fragile X Syndrome
09/07/2018 - 12:55 -
TRU NIAGEN® to be featured at the American Association of Naturopathic Physicians Annual Convention and the 2018 Healthy Aging Summit
09/07/2018 - 12:30 -
Athenex Names Timothy Cook as Senior Vice President of Global Commercial Oncology
09/07/2018 - 12:30
Pages